Compartir
array:23 [ "pii" => "S0025775300712176" "issn" => "00257753" "doi" => "10.1016/S0025-7753(00)71217-6" "estado" => "S300" "fechaPublicacion" => "2000-01-01" "aid" => "71217" "copyright" => "Elsevier España, S.L.. Todos los derechos reservados" "copyrightAnyo" => "2000" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Med Clin. 2000;114:128-31" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1577 "formatos" => array:3 [ "EPUB" => 5 "HTML" => 1478 "PDF" => 94 ] ] "itemSiguiente" => array:18 [ "pii" => "S0025775300712188" "issn" => "00257753" "doi" => "10.1016/S0025-7753(00)71218-8" "estado" => "S300" "fechaPublicacion" => "2000-01-01" "aid" => "71218" "copyright" => "Elsevier España, S.L." "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Med Clin. 2000;114:132-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 4763 "formatos" => array:3 [ "EPUB" => 6 "HTML" => 4593 "PDF" => 164 ] ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Originales</span>" "titulo" => "Factores determinantes del abandono del tabaquismo durante el embarazo" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "132" "paginaFinal" => "135" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Determinant factors of smoking cessation during pregnancy" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Mireia Jané, Manuel Nebot, Margarita Badí, Bernardo Berjano, Maribel Muñoz, M. Carmen Rodríguez, Àlex Querol, y Luis Cabero" "autores" => array:8 [ 0 => array:2 [ "nombre" => "Mireia" "apellidos" => "Jané" ] 1 => array:2 [ "nombre" => "Manuel" "apellidos" => "Nebot" ] 2 => array:2 [ "nombre" => "Margarita" "apellidos" => "Badí" ] 3 => array:2 [ "nombre" => "Bernardo" "apellidos" => "Berjano" ] 4 => array:2 [ "nombre" => "Maribel" "apellidos" => "Muñoz" ] 5 => array:2 [ "nombre" => "M. Carmen" "apellidos" => "Rodríguez" ] 6 => array:2 [ "nombre" => "Àlex" "apellidos" => "Querol" ] 7 => array:2 [ "nombre" => "y Luis" "apellidos" => "Cabero" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775300712188?idApp=UINPBA00004N" "url" => "/00257753/0000011400000004/v1_201307291355/S0025775300712188/v1_201307291355/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0025775300712164" "issn" => "00257753" "doi" => "10.1016/S0025-7753(00)71216-4" "estado" => "S300" "fechaPublicacion" => "2000-01-01" "aid" => "71216" "copyright" => "Elsevier España, S.L." "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Med Clin. 2000;114:121-7" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2328 "formatos" => array:3 [ "EPUB" => 5 "HTML" => 2154 "PDF" => 169 ] ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Originales</span>" "titulo" => "Utilidad de la prueba de ejercicio cardiopulmonar en pacientes con miopatía mitocondrial" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "121" "paginaFinal" => "127" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Role of cardiopulmonary exercise test in patients with mitochondrial myopathies" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:2 [ 0 => array:2 [ "autoresLista" => "J. Fernández, T. Montemayor, J. Castillo" "autores" => array:3 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Fernández" ] 1 => array:2 [ "nombre" => "T." "apellidos" => "Montemayor" ] 2 => array:2 [ "nombre" => "J." "apellidos" => "Castillo" ] ] ] 1 => array:2 [ "autoresLista" => "J. Bautista, R. Márquez, L. Jiménezb, J. Arenas, Y. Campos" "autores" => array:5 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Bautista" ] 1 => array:2 [ "nombre" => "R." "apellidos" => "Márquez" ] 2 => array:2 [ "nombre" => "L." "apellidos" => "Jiménezb" ] 3 => array:2 [ "nombre" => "J." "apellidos" => "Arenas" ] 4 => array:2 [ "nombre" => "Y." "apellidos" => "Campos" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775300712164?idApp=UINPBA00004N" "url" => "/00257753/0000011400000004/v1_201307291355/S0025775300712164/v1_201307291355/es/main.assets" ] "es" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Originales</span>" "titulo" => "Trasplante de células progenitoras hematopoyéticas como tratamiento de rescate en pacientes con linfomas no hodgkinianos agresivos" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "128" "paginaFinal" => "131" ] ] "autores" => array:2 [ 0 => array:4 [ "autoresLista" => "Reyes Arranz, César Sanz-Rodríguez, Francisco J. Pajuelo, Carmen Martínez Chamorro, José M<span class="elsevierStyleSup">a</span> Fernández Rañada." "autores" => array:5 [ 0 => array:4 [ "nombre" => "Reyes" "apellidos" => "Arranz" "email" => array:1 [ 0 => "rarranzs@aehh.org" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "César" "apellidos" => "Sanz-Rodríguez" ] 2 => array:2 [ "nombre" => "Francisco J." "apellidos" => "Pajuelo" ] 3 => array:2 [ "nombre" => "Carmen" "apellidos" => "Martínez Chamorro" ] 4 => array:2 [ "nombre" => "José M<span class="elsevierStyleSup">a</span>" "apellidos" => "Fernández Rañada." ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Anatomía Patológica del Hospital Universitario de la Princesa. Leganés. Madrid" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "*" "correspondencia" => "Correspondencia: Servicio de Hematología. Hospital Universitario de la Princesa. Diego de León, 62. 28006 Madrid." ] ] ] 1 => array:3 [ "autoresLista" => "Agustín Acevedo, Guillermo Pérez" "autores" => array:2 [ 0 => array:3 [ "nombre" => "Agustín" "apellidos" => "Acevedo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff00005" ] ] ] 1 => array:3 [ "nombre" => "Guillermo" "apellidos" => "Pérez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff00010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicios de Hematología Leganés. Madrid" "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff00005" ] 1 => array:3 [ "entidad" => "Servicio de Hematología del Hospital Severo Ochoa. Leganés. Madrid" "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff00010" ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Hematopoietic stem cell transplantation as salvage treatment in patients with aggresive non-Hodgkin's lymphoma" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "1999-09-27" "fechaAceptado" => "1999-11-30" "PalabrasClave" => array:1 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec220512" "palabras" => array:4 [ 0 => "Linfoma no hodgkiniano" 1 => "Trasplante de células progenitoras hematopoyéticas" 2 => "Quimioterapia" 3 => "Quimioterapia MACOP/UACOP-B" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:1 [ "resumen" => "<span class="elsevierStyleSectionTitle">Fundamento</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">La realizacion precoz del trasplante de celulas progenitoras hematopoyeticas (TPH)en pacientes con linfomas no hodgkinianos (LNH) agresivos es una indicacion controvertida.</p> <span class="elsevierStyleSectionTitle">Metodos</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Analisis retrospectivo de 86 pacientes con LNH agresivos tratados con quimioterapiaMACOP/VACOP-B. El TPH se utilizo como tratamiento de rescate en pacientes con edad inferioro igual a 65 anos con progresion o recaida quimiosensible. Se determinaron las supervivenciaslibre de progresion (SLP) y global (SG) con el metodo de Kaplan-Meier. Se compararon losporcentajes de respuesta y las funciones de supervivencia entre los grupos del Indice PronosticoInternacional (IPI) mediante las pruebas χ<span class="elsevierStyleSup">2</span> y log-rank, respectivamente</p> <span class="elsevierStyleSectionTitle">Resultados</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">La mediana de edad de los pacientes fue de 48 anos. El 22% tenian LNH-T y el57% tenian IPI de intermedio-alto y alto riesgo. Hubo 6 muertes por toxicidad (7%), y 42(48,8%) pacientes fracasaron al tratamiento de primera linea. De ellos, 31 fueron candidatos aTPH por edad inferior o igual a 65 anos, aunque finalmente se trasplantaron 21 (incluyendo13 de mayor riesgo). Se observo una asociacion estadisticamente significativa entre la SLP y elIPI: 61,9% para los grupos bajo y bajo-intermedio (menor riesgo) frente al 28,2% para los demayor riesgo (p = 0,0007). Con una mediana de seguimiento de 4,8 anos, la SG fue del80,5% para los grupos de menor riesgo frente al 52,6% (p = 0,01) para los de mayor riesgo, ydel 83,7% frente al 62,0% (p = 0,02) para los mismos grupos en pacientes con edad inferior oigual a 65 anos. La mediana de seguimiento posfracaso del tratamiento quimioterapico fue de42,7 meses.</p> <span class="elsevierStyleSectionTitle">Conclusiones</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">En este analisis retrospectivo la SG de los pacientes con LNH agresivos utilizandoel TPH como tratamiento de rescate es similar a la comunicada utilizando el TPH mas precozmente.</p>" ] "en" => array:1 [ "resumen" => "<span class="elsevierStyleSectionTitle">Background</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">The indication of early hematopoietic stem cell transplantation (HSCT) in patientswith aggressive non-Hodgkin's lymphoma (LNH) is controversial.</p> <span class="elsevierStyleSectionTitle">Patients and methods</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Retrospective analysis of 86 patients with aggressive NHL treated withMACOP/VACOP-B chemotherapy. HSCT was performed as salvage treatment to patients under65 years of age with proggressive disease or chemosensitive relapse. Progression free survival(PFS) and overall survival (OS) were determined by the Kaplan-Meier method. Rates of responseand survival functions were compared between the International Prognostic Index (IPI)groups using the Chi-square and log-rank tests, respectively.</p> <span class="elsevierStyleSectionTitle">Results</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Patients median age was 48 years; 22% had T cell NHL and 57% had intermediatehighand high risk (high risk) IPI. There were 6 toxic deaths (7%), and treatment failure wasobserved in 42 patients (48.8%). Thirty one of them were candidates for TPH due to age under65 years, although 21 were finally transplanted (including 13 with high risk IPI). A significantassociation between PFS and IPI was observed, 61.9% for low risk (low and low-intermediate)versus 28.2% for high risk groups (p = 0.0007). With a median follow up of 4.8 years, OS was64%; 80.5% for low risk versus 52.6% for high risk IPI groups (p = 0.01), and 83.7% versus62% for the same groups in patients under 65 years of age (p = 0.02). The median follow upafter failure to chemotherapy was 42.7 months.</p> <span class="elsevierStyleSectionTitle">Conclusions</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">In this retrospective study, OS rate in high risk IPI patients with NHL using HSCTas salvage treatment is similar to that reported using HSCT during earlier phases of treatment.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Referencias Bibliográficas" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:21 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphomas" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.I. Fisher" 1 => "E.R. Gaynor" 2 => "S. Dahlberg" 3 => "M.M. Oken" 4 => "T.M. Grogan" 5 => "E.M. Mize" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM199304083281404" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1993" "volumen" => "328" "paginaInicial" => "1002" "paginaFinal" => "1006" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7680764" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mead GM and Whitehouse JMA. Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade Non-Hodgkin's lymphoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.W. Sweetenham" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/jco.1991.9.12.2202" "Revista" => array:6 [ "tituloSerie" => "J Clin Oncol" "fecha" => "1991" "volumen" => "9" "paginaInicial" => "2202" "paginaFinal" => "2209" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1720454" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A predictive model for aggressive NHL: the International non-Hodgkin's lymphoma prognostic factors project" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "The International Non-Hodgkin's Lymphoma Prognostic Factors Project" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "N Engl J Med" "fecha" => "1993" "volumen" => "29" "paginaInicial" => "987" "paginaFinal" => "994" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy sensitive non-Hodgkin's lymphoma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Philip" 1 => "C. Guglielmi" 2 => "A. Hagenbeek" 3 => "R. Somers" 4 => "H. Van der Lelie" 5 => "D. Bron" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM199512073332305" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1985" "volumen" => "333" "paginaInicial" => "1540" "paginaFinal" => "1545" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7477169" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.G. Gribben" 1 => "A.H. Goldstone" 2 => "D.C. Linch" 3 => "G. Taghipour" 4 => "A.K. McMillan" 5 => "R.L. Souhami" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/jco.1989.7.11.1621" "Revista" => array:6 [ "tituloSerie" => "J Clin Oncol" "fecha" => "1989" "volumen" => "7" "paginaInicial" => "1621" "paginaFinal" => "1629" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2809678" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tratamiento de los linfomas no hodgkinianos agresivos" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. López" 1 => "C. Palacio" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "1998" "volumen" => "110" "paginaInicial" => "614" "paginaFinal" => "618" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Failure of first line induction high dose chemotherapy in poor risk patients with aggressive lymphoma: updated results of the randomized LNH-93 study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Reyes" 1 => "E. Lepage" 2 => "P. Morel" 3 => "P. Lederlin" 4 => "B. Coiffier" 5 => "H. Tilly" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Blood" "fecha" => "1997" "volumen" => "Supl 1" "paginaInicial" => "549" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High dose chemotherapy with autologous stem cell transplantation in aggressive NHL" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "U. Kaiser" 1 => "L. Uebelacker" 2 => "K. Havemann" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Ann Oncol" "fecha" => "1999" "volumen" => "10" "numero" => "Supl 3" "paginaInicial" => "76" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Consolidation ABMT after standard chemotherapy vs CHVmP/BV alone for primary intermediate and high grade NHL: a randomized Phase III EORTC Study. Program/Proc Am Soc Clin Oncol" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.C. Kluin-Nelemans" 1 => "V. Zagonel" 2 => "J. Thomas" 3 => "I. Teodorovic" 4 => "A. Anastasopoulo" 5 => "D. Bron" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Thirty Fith Ann Meeting" "fecha" => "1999" "volumen" => "18" "paginaInicial" => "2" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Autologous bone marrow transplantation in poor prognosis intermediate grade and high grade B-cell non Hodgkin's lymphoma in first remission: a pilot study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.S. Freedman" 1 => "T. Takvorian" 2 => "D. Neuberg" 3 => "P. Mauch" 4 => "S. Rabinobe" 5 => "K.C. Anderson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/jco.1993.11.5.931" "Revista" => array:6 [ "tituloSerie" => "J Clin Oncol" "fecha" => "1993" "volumen" => "11" "paginaInicial" => "931" "paginaFinal" => "936" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8487057" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Survival benefit from high dose therapy with autologous blood progenitor cell transplantation in poor prognosis non-Hodgkin's lymphoma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. Pettengall" 1 => "J.A. Radford" 2 => "G.R. Morgenstern" 3 => "J.H. Scarffe" 4 => "M. Harris" 5 => "P.J. Woll" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/jco.1996.14.2.586" "Revista" => array:6 [ "tituloSerie" => "J Clin Oncol" "fecha" => "1996" "volumen" => "14" "paginaInicial" => "586" "paginaFinal" => "592" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8636775" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Autologous bone marrow transplantation for non-Hodgkin's lymphoma in first remission [carta]" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J. Sierra" 1 => "E. Conde" 2 => "E. Montserrat" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Blood" "fecha" => "1993" "volumen" => "81" "paginaInicial" => "1968" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8461480" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH 87-2" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Haioun" 1 => "E. Lepage" 2 => "C. Gisselbrecht" 3 => "Y. Bastion" 4 => "B. Coiffier" 5 => "P. Brice" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Clin Oncol" "fecha" => "1997" "volumen" => "15" "paginaInicial" => "1311" "paginaFinal" => "1317" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "VACOP-B versus VACOP- B plus autologous bone marrow transplantion for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Santini" 1 => "L. Salvagno" 2 => "P. Leoni" 3 => "T. Chisesi" 4 => "C. De Souza" 5 => "M.R. Sertoni" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/jco.1998.16.8.2796" "Revista" => array:6 [ "tituloSerie" => "J Clin Oncol" "fecha" => "1998" "volumen" => "16" "paginaInicial" => "2796" "paginaFinal" => "2802" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9704732" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Gianni" 1 => "M. Bregni" 2 => "S. Siena" 3 => "C. Brambilla" 4 => "M. Di Nicola" 5 => "F. Lombardi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM199705013361804" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1997" "volumen" => "336" "paginaInicial" => "1290" "paginaFinal" => "1297" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9113932" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Patient selection in high dose chemotherapy trials: relevance in high risk breast cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. García Carbonero" 1 => "M. Hidalgo" 2 => "L. Paz-Ares" 3 => "J. Calzas" 4 => "H. Gómez" 5 => "J.A. Guerra" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/jco.1997.15.10.3178" "Revista" => array:6 [ "tituloSerie" => "J Clin Oncol" "fecha" => "1997" "volumen" => "15" "paginaInicial" => "3178" "paginaFinal" => "3184" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9336353" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "P. Klimo" 1 => "J.M. Connors" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Intern Med" "fecha" => "1985" "volumen" => "102" "paginaInicial" => "596" "paginaFinal" => "602" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2580468" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "MACOP-B and VACOP-B in diffuse large-cell lymphomas and MOPP/ABV in Hodgkin's disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S.E. O'Reilly" 1 => "P. Hoskins" 2 => "P. Klimo" 3 => "J.M. Connors" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Oncol" "fecha" => "1991" "volumen" => "2" "paginaInicial" => "17" "paginaFinal" => "23" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1710485" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high grade non-Hodgkin's" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Philip" 1 => "J.O. Armitage" 2 => "G. Spitzer" 3 => "F. Chauvin" 4 => "S. Janannath" 5 => "J.Y. Cahn" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM198706113162401" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1987" "volumen" => "316" "paginaInicial" => "1493" "paginaFinal" => "1498" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3295541" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognostic Factors in Aggressive Non-Hodgkin's Lymphoma: Who has «high-risk» disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M.A. Shipp" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Blood" "fecha" => "1994" "volumen" => "83" "paginaInicial" => "1165" "paginaFinal" => "1173" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8118021" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diffuse large cell lymphoma (DLCL): when to intensify and transplant? i.e to transplant in first CR or in first relapse? Program/Proc Am Soc of Clin Oncol" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "T. Philip" 1 => "C. Sebban" 2 => "P. Biron" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Thirty Fith Ann Meeting" "fecha" => "1999" "volumen" => "188" "paginaInicial" => "12" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/00257753/0000011400000004/v1_201307291355/S0025775300712176/v1_201307291355/es/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/00257753/0000011400000004/v1_201307291355/S0025775300712176/v1_201307291355/es/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775300712176?idApp=UINPBA00004N" ]
